- Home
- EXPD vs NBIX Comparison
EXPD vs NBIX Comparison
Compare EXPD & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXPD
- NBIX
- Stock Information
- Founded
- EXPD 1979
- NBIX 1992
- Country
- EXPD United States
- NBIX United States
- Employees
- EXPD N/A
- NBIX N/A
- Industry
- EXPD Oil Refining/Marketing
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EXPD Consumer Discretionary
- NBIX Health Care
- Exchange
- EXPD Nasdaq
- NBIX Nasdaq
- Market Cap
- EXPD 16.3B
- NBIX 14.4B
- IPO Year
- EXPD N/A
- NBIX 1996
- Fundamental
- Price
- EXPD $136.99
- NBIX $150.87
- Analyst Decision
- EXPD Sell
- NBIX Strong Buy
- Analyst Count
- EXPD 10
- NBIX 18
- Target Price
- EXPD $126.11
- NBIX $172.06
- AVG Volume (30 Days)
- EXPD 1.4M
- NBIX 1.1M
- Earning Date
- EXPD 11-04-2025
- NBIX 10-28-2025
- Dividend Yield
- EXPD 1.12%
- NBIX N/A
- EPS Growth
- EXPD 20.10
- NBIX 12.44
- EPS
- EXPD 6.15
- NBIX 4.19
- Revenue
- EXPD $11,167,760,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- EXPD $3.06
- NBIX $23.68
- Revenue Next Year
- EXPD N/A
- NBIX $18.02
- P/E Ratio
- EXPD $22.36
- NBIX $36.35
- Revenue Growth
- EXPD 12.54
- NBIX 19.61
- 52 Week Low
- EXPD $100.47
- NBIX $84.23
- 52 Week High
- EXPD $140.72
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- EXPD 71.95
- NBIX 59.16
- Support Level
- EXPD $117.45
- NBIX $133.62
- Resistance Level
- EXPD $140.72
- NBIX $157.67
- Average True Range (ATR)
- EXPD 3.37
- NBIX 4.58
- MACD
- EXPD 2.15
- NBIX 0.98
- Stochastic Oscillator
- EXPD 84.39
- NBIX 67.98
About EXPD Expeditors International of Washington Inc.
Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 35% of consolidated gross revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.